SCHEMBL7615482

SCHEMBL7615482

CC(CS)SC(CCC(=O)O)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 7/20 0.47
CYP1A2 P05177 2/20 0.45
ENPEP Q07075 5/20 0.43
ANPEP P15144 4/20 0.43
GABRP O00591 2/20 0.41
GABRD O14764 2/20 0.41
GABRA1 P14867 2/20 0.41
GABRB1 P18505 2/20 0.41
GABRG2 P18507 2/20 0.41
GABRB3 P28472 2/20 0.41
GABRA5 P31644 2/20 0.41
GABRA3 P34903 2/20 0.41
GABRA2 P47869 2/20 0.41
GABRB2 P47870 2/20 0.41
GABRA4 P48169 2/20 0.41
GABRE P78334 2/20 0.41
GABRA6 Q16445 2/20 0.41
GABRG1 Q8N1C3 2/20 0.41
GABRG3 Q99928 2/20 0.41
GABRQ Q9UN88 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7611637 0.75 FOLH1 (0.58) FOLH1CYP1A2ENPEPANPEPGRM3
Hydrochloric Acid SCHEMBL7712880 0.71 ENPEP (0.52) FOLH1CYP1A2ENPEPANPEPGABRP
SCHEMBL7608322 0.69 FOLH1 (0.48) FOLH1CYP1A2ENPEPANPEPTET2
SCHEMBL4979183 0.69
SCHEMBL30191691 0.67 TET2 (0.46) FOLH1CYP1A2ENPEPANPEPGABRP
SCHEMBL5052692 0.67 FOLH1 (0.52) FOLH1CYP1A2ENPEPANPEPGABRP
Hydrochloric Acid SCHEMBL7710591 0.66
SCHEMBL9315899 0.66 GABRP (0.54) FOLH1CYP1A2ENPEPANPEPGABRP
SCHEMBL29009323 0.66 GABRP (0.48) FOLH1CYP1A2ENPEPANPEPGABRP
Hydrochloric Acid SCHEMBL16667716 0.65 GABRP (0.59) FOLH1CYP1A2ENPEPANPEPGABRP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458775-B1 N-ACETYLATED .ALPHA.-LINKED ACIDIC DIPEPTIDASE (NAALADASE) INHIBITORS ENZYME ACTIVITY, PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH INHIBITORS, AND METHODS OF THEIR USE TO INHIBIT NAALADASE ENZYME ACTIVITY, THEREBY EFFECTING NEURONAL GUILFORD PHARMACEUTICAL INC. 2002-10-01 US disclosed
US-6265609-B1 INHIBIT N-ACETYLATED .ALPHA.-LINKED ACIDIC DIPEPTIDASE (NAALADASE) ENZYME ACTIVITY; IN DRUGS TO TREAT GLUTAMATE ABNORMALITIES; COMPULSIVE DISORDERS AND PROSTATE DISEASES, TO EFFECT NEURONAL ACTIVITIES GUILFORD PHARMACEUTICALS INC. 2001-07-24 US disclosed